Ruchika Husa, MD - PowerPoint PPT Presentation

1 / 62
About This Presentation
Title:

Ruchika Husa, MD

Description:

Title: PowerPoint Presentation Author: Daniel Davis, MD Last modified by: Husa, Ruchika Document presentation format: On-screen Show (4:3) Other titles – PowerPoint PPT presentation

Number of Views:98
Avg rating:3.0/5.0
Slides: 63
Provided by: Daniel1255
Learn more at: http://u.osu.edu
Category:

less

Transcript and Presenter's Notes

Title: Ruchika Husa, MD


1
SCD and Therapeutic Hypothermia
  • Ruchika Husa, MD
  • OSU Wexner Medical Center

2
Clinical Vignette
  • Young female found down by coworker in the UCSD
    temporary office building.
  • No bystander CPR upon code teams arrival.
  • pulseless, non-responsive.

2
3
(No Transcript)
4
Post Resuscitation
  • Cooled. Full neurologic recovery.
  • No baseline ECG abnormalities.
  • Cardiac MRI without anatomic abnormalities.
  • ICD and discharge after 12 days.

4
5
Objectives
  • Evidence behind therapeutic hypothermia
  • Patient selection
  • Methods of cooling
  • Timing of cooling
  • Degree of hypothermia
  • Duration of hypothermia

6
Why should we cool?
7
(No Transcript)
8
Reperfusion Injury
Reperfusion
Ischemia
9
Why should we cool?
  • Reperfusion injury
  • Necrosis/apoptosis
  • Inflammation
  • Reactive oxygen species
  • Improved defibrillation
  • B-blocker effect?

10
Historic perspective
  • Open heart surgeries moderate hypothermia (28C
    to 32C) used since the 1950s to protect the brain
    during intra-op global ischemia.
  • Successful use of hypothermia after SCD described
    in 1950s but subsequently abandoned due to lack
    of evidence.

10
11
Cont.
  • Guideline 2000 for CPR and Emergency
    Cardiovascular care did not include therapeutic
    hypothermia after arrest.
  • In 2002 the results of 2 prospective randomized
    trials lead to addition of this recommendation to
    the guidelines.

11
12
Why should we cool?
13
  • Entry criteria witnessed cardiac arrest with
    first resuscitation attempt 5-15 min after
    collapse, ROSC (lt60 from collapse), persistent
    coma, VF.
  • Exclusion criteria severe cardiogenic shock,
    hypotension (SBP lt90mmHg), persistent
    arrhythmias, primary coagulopathy.
  • Approximately 92 of screened participants were
    excluded.

14
PROTOCOL
  • In European study, patients were cooled using a
    special mattress and ice packs. Target temp 32?
    to 34? for 24 hours. Rewarming over 8 hours.
  • Australian study used cold packs in the field.
    Target temp 33? for 12 hours. Rewarming over 6
    hours.

15
Why should we cool?
Hypothermia After Cardiac Arrest Study Group
(2002) NEJM
16
NEUROLOGIC OUTCOME AND MORTALITY AT SIX MONTHS
  • OUTCOME NORMOTHERMIA
    HYPOTHERMIA RISK RATIO (95 CI) P VALUE

  • no./total no. ()
  • Favorable neurologic 54/137 (39)
    75/136 (55) 1.40 (1.081.81) 0.009
  • outcome
  • Death 6/138 (55)
    56/137 (41) 0.74 (0.580.95)
    0.02

16
17
ALS Task Force recommendation in 2002
  • Unconscious adult patients with spontaneous
    circulation after out-of-hospital cardiac arrest
    should be cooled to 32? to 34? for 12-24 hours
    when initial rhythm was ventricular fibrillation.
  • Such cooling may be beneficial for other rhythms
    or in-hospital cardiac arrest.

18
Why should we cool?
19
Post-Arrest Care
  • Cooling
  • Emergency PCI
  • Good ICU care
  • Rehab?

20
Post-Arrest Care
Sunde (2007) Resuscitation
21
Prognostic factors affecting survival with
favorable outcomes
Prognostic factors Adjusted odds ratio
95 CI Intervention period
4.47 1.6012.52 Age gt70
0.48
0.171.37 Time to ROSC
0.91
0.850.96 Ambulance response time 0.91
0.781.07 Initial VF
1.84
0.3310.41
22
Post-Arrest Care
23
Prehospital Cooling Issues
  • Does post-arrest cooling in the field really make
    that much difference?
  • Should we be cooling during arrest?
  • Does cooling distract from other tasks?
  • Are there patients with complications from
    cooling that cannot be identified in the field?

24
When should we cool?
  • Cellular approach
  • Pre-treatment
  • Necrosis/apoptosis
  • Inflammation/ROS
  • Pragmatic approach
  • Intra-arrest
  • Prehospital ROSC
  • ED
  • ICU

25
When should we cool?
26
When should we cool?
Hypothermia After Cardiac Arrest Study Group
(2002) NEJM
27
When should we cool?
Abella (2004) Circulation
28
When should we cool?
Kuboyama (1993) Crit Care Med
29
When should we cool?
Nozari (2006) Circulation
30
When should we cool?
Nozari (2006) Circulation
31
Prehospital Hypothermia
32
Prehospital Hypothermia
Kim (2007) Circulation
33
Prehospital Hypothermia
Kim (2007) Circulation
34
Who should we cool?
  • All arrest victims?
  • Brain doesnt know the rhythm
  • Only ventricular fibrillation?
  • Evidence-based approach
  • Non-VF patients?
  • Infection
  • CHF
  • Bleeding

35
Resuscitation - September 2011
Mild therapeutic hypothermia is associated with
favourable outcome in patients after cardiac
arrest with non-shockable rhythms
- Retrospective analysis of adult cardiac arrest
survivors suffering a witnessed out-of-hospital
cardiac arrest with asystole or pulseless
electric activity as the first documented
rhythm. - Patients who were treated with mild
therapeutic hypothermia were more likely to have
good neurological outcomes, odds ratio of 1.84
(95 confidence interval 1.083.13). -
Mortality was significantly lower in the
hypothermia group (odds ratio 0.56 95
confidence interval 0.340.93).
36
Resuscitation - February 2012Does
therapeutic hypothermia benefit adult cardiac
arrest patients presenting with non-shockable
initial rhythms? A systematic review and
meta-analysis of randomized and non-randomized
studies.
  • TH is associated with reduced in-hospital
    mortality for adults patients resuscitated from
    non-shockable CA.
  • However, most of the studies had substantial
    risks of bias and quality of evidence was very
    low.
  • Further high quality randomized clinical trials
    would confirm the actual benefit of TH in this
    population.

36
37
Recent trial
38
Trial design
  • Randomized 950 unconscious adults after
    out-of-hospital cardiac arrest of presumed
    cardiac cause (irrespective of initial rhythm) to
    targeted temperature management at either 33C or
    36C.
  • The primary outcome was all-cause mortality
    through the end of the trial.
  • Secondary outcomes included a composite of poor
    neurologic function or death at 180 days

39
Nielsen N et al. N Engl J Med 20133692197-2206.
Body Temperature during the Intervention Period.
40
Nielsen N et al. N Engl J Med 20133692197-2206.
Probability of Survival through the End of the
Trial.
41
Results
42
Complications of Hypothermia
  • Coagulopathy
  • Overshoot?
  • Hemodynamic
  • Dysrhythmias
  • Infectious
  • Sepsis, pneumonia
  • Electrolyte disturbances

43
Who should we cool?
44
(No Transcript)
45
(No Transcript)
46
How should we cool?
  • Surface cooling
  • Evaporative
  • Ice packs/chemical
  • Cooling pads
  • Internal strategies
  • Cooled intravenous fluids
  • Intravascular catheters
  • Intranasal catheters

47
Cooling Catheters
48
Surface Cooling
49
How cold?
  • Official recommendations
  • Target temp 32-34o C
  • ? 36?C
  • Threshold for effect?
  • Adverse effects?
  • Really cold?
  • Different mechanisms

50
(No Transcript)
51
Deep Hypothermia
20 min Circulatory Arrest
52
Deep Hypothermia
53
How long?
  • Official recommendations
  • Inflammatory pattern
  • Peak at 72 hours
  • Customized
  • Depth and duration

54
How long?
55
Assessing neurologic recovery
  • New thoughts on longer waiting time prior to
    withdrawal of care.

55
56
Suggested protocol
  • OOHCA with ROSC
  • Iced saline in EMS or ED
  • Cooling catheter ? surface cooling with pads
  • Median time from ED arrival to initiation of
    hypothermia lt 30min
  • Bladder temp probe
  • Avoid shivering
  • Aggressively control hyperthermia (fever) post
    rewarming.

57
(No Transcript)
58
(No Transcript)
59
(No Transcript)
60
(No Transcript)
61
(No Transcript)
62
Parting Thoughts
  • More patients should be closely monitored for
    hyperthermia
  • The complications of hypothermia should be
    anticipated, not avoided
  • Future research may help clarify the optimal
    dose and duration of hypothermia
Write a Comment
User Comments (0)
About PowerShow.com